Background Multiple system atrophy is a rare, fatal neurodegenerative disorder with
symptoms of autonomic failure plus parkinsonism, cerebellar ataxia, or both. We report …

Background Multiple system atrophy (MSA) is a fatal and still poorly understood
degenerative movement disorder that is characterised by autonomic failure, cerebellar …

Abstract See Colosimo and Berardelli (doi: 10.1093/brain/awv303) for a scientific
commentary on this article. Multiple system atrophy is characterized by autonomic failure …

Multiple system atrophy (MSA) is a rare neurodegenerative disease, with limited
understanding of disease progression and prognostic factors. We leveraged the data of a …

Background Multiple system atrophy (MSA) is diverse in clinical phenotype, disease
progression, and prognosis. Sudden death is a leading cause of death in patients with MSA …

Multiple system atrophy (MSA) is a devastating and fatal neurodegenerative disorder. The
clinical presentation of this disease is highly variable, with parkinsonism, cerebellar ataxia …

Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative
disorder that presents with autonomic failure in combination with parkinsonism or cerebellar …

Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …

Objective: To assess the accuracy of a clinical diagnosis of multiple system atrophy (MSA)
and compare it to the Quinn and Consensus criteria for MSA using neuropathologically …

Background: A consensus conference on multiple system atrophy (MSA) in 1998
established criteria for diagnosis that have been accepted widely. Since then, clinical …